To express the sense of the Senate concerning comparative effectiveness studies.
What it does: Adds SEC. __. SENSE OF THE SENATE CONCERNING COMPARATIVE EFFECTIVENESS STUDIES at the appropriate place in title IIIWhat it changes
1 change to S.Con.Res. 18
Adds SEC. __. SENSE OF THE SENATE CONCERNING COMPARATIVE EFFECTIVENESS STUDIES at the appropriate place in title III
Adds a sectionInserted: SEC. __. SENSE OF THE SENATE CONCERNING COMPARATIVE EFFECTIVENESS STUDIES.
Inserted: It is the Sense of the Senate that--
Inserted: (1) the overall discretionary levels set in this resolution assume $75,000,000 in new budget authority in fiscal year 2006 and new outlays that flow from this budget authority in fiscal year 2006 and subsequent years, to fund research and ongoing systematic reviews, consistent with efforts currently undertaken by the Agency for Health Care Research and Quality designed to improve scientific evidence related to the comparative effectiveness and safety of prescription drugs and other treatments and to disseminate the findings from such research to health care practitioners, consumers, and health care purchasers; and
Inserted: (2) knowledge gaps identified through such efforts be addressed in accordance with the authorizing legislation and with oversight from the committees of subject matter jurisdiction.
The amendment doesn't say where this goes; the clerk decides.
Original wording
At the appropriate place in title III, insert the following:
Read automatically from the Congressional Record. Check the original before relying on it.
As printed
At the appropriate place in title III, insert the following:
SEC. __. SENSE OF THE SENATE CONCERNING COMPARATIVE EFFECTIVENESS STUDIES.
It is the Sense of the Senate that--
(1) the overall discretionary levels set in this resolution assume $75,000,000 in new budget authority in fiscal year 2006 and new outlays that flow from this budget authority in fiscal year 2006 and subsequent years, to fund research and ongoing systematic reviews, consistent with efforts currently undertaken by the Agency for Health Care Research and Quality designed to improve scientific evidence related to the comparative effectiveness and safety of prescription drugs and other treatments and to disseminate the findings from such research to health care practitioners, consumers, and health care purchasers; and
(2) knowledge gaps identified through such efforts be addressed in accordance with the authorizing legislation and with oversight from the committees of subject matter jurisdiction.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment proposed (on the floor): Amendment SA 154 proposed by Senator Gregg for Senator Clinton.(consideration: CR S2941-2942, S2943)
March 17, 2005
View full timeline
Senate amendment proposed (on the floor): Amendment SA 154 proposed by Senator Gregg for Senator Clinton.(consideration: CR S2941-2942, S2943)
March 17, 2005
Senate amendment agreed to: Amendment SA 154 as modified agreed to in Senate by Unanimous Consent.
March 17, 2005
Amendment SA 154 proposed by Senator Gregg for Senator Clinton. (consideration: CR S2941-2942, S2943) To express the sense of the Senate concerning comparative effectiveness studies.
March 17, 2005
Amendment SA 154 as modified agreed to in Senate by Unanimous Consent. (text as modified: CR S2942)
March 17, 2005
Amendment SA 154, previously agreed to, was modified by Unanimous Consent.
March 17, 2005
Senate amendment submitted
March 15, 2005